1. http://www.fiercepharma.com/story/sanofi-tried-and-failed-af...
Ten years later I made another medical device investment. Again, good IP protection, FDA approved, clear data showing life-saving benefits. This one failed because the technical founders decided to go off the ranch and have a turf battle with the CEO.
The Murphy factor in this sector seems pretty high to me.
I think the difference is with pure software you are just dealing with human created complexity - with biotech you also have nature’s complexity to deal with too. Mix the two together and spice it up with some unbelievably stringent regulations and you have a recipe for a lot of heartburn.
I got this idea after watching the Vice interview with Martin Shkreli (obviously not a role model)[1]
Shkreli made the leap from hedge funds (betting against pharma companies) into becoming the CEO of a pharma company, which apparently does research in addition jacking up the prices of HIV drugs (Shkreli actually gives out chemistry lessons on youtube[2]).
So maybe some geeks could try getting funding, buy up some underappreciated, undervalued but already FDA approved drugs, and using the cashflow to do further research, or develop cool new products or services in the healthcare space instead of the traditional, risky route. (I'm not advocating jacking up the prices of critical lifesaving drugs obviously).
This may also work for some healthcare software apps.
[0] http://www.emergogroup.com/resources/articles/fda-510k-clear...